TMCnet News
Myomo, Inc. Files Registration Statement for Proposed Follow-On OfferingMyomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a commercial stage medical robotics company, announced the filing of a registration statement with the U.S. Securities and Exchange Commission (SEC (News - Alert)) relating to a proposed underwritten follow-on public offering of shares of its common stock and accompanying warrants to purchase common stock. A registration statement relating to these securities has been filed with the SEC but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. This press release is not an offer for sale of the securities in the United States or in any other jurisdiction where such offer is prohibited, and such securities may not be offered or sold in the United States absent registration or an exemption from registration under the United States Securities Act of 1933, as amended. In connection with the proposed offering described above, all shares held by all officers and directors and certain other shareholders of the Company became subject to lock-up restrictions pursuant to agreements entered into with Roth Capital Partners, LLC ("Roth"). In addition, Tripoint Global Equities, LLC ("Tripoint") is releasing, effective November 16, 2017,all of the shares of common stock subject to lock-up agreements entered into with it in connection with the Company's June 2017 initial public offering. As a result, approximately 59% of shares released from lock-up restrictions by Tripoint, which includes all of the shares held by all officers and directors of the Company, will remain subject to lock-up restrictions pursuant to agreements with Roth.
About Myomo
Forward Looking Statements
View source version on businesswire.com: http://www.businesswire.com/news/home/20171113006270/en/ |